1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2023Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study ESMO OPEN
2023Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on? FRONTIERS IN PUBLIC HEALTH
2023Risk of cancer in patients with insomnia: Nationwide retrospective cohort study (2009-2018) PLOS ONE
2023Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study Endocrinology and Metabolism(대한내분비학회지)
2023Risk Factors and Outcomes With Progressive Mitral Annular Calcification JOURNAL OF THE AMERICAN HEART ASSOCIATION
2023Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer ESMO OPEN
2023ResponseGASTROINTESTINAL ENDOSCOPY
2023Reply: The Clinical Outcomes and Success of Posterior Wall Isolation Using a "Box" Approach JACC. Clinical Electrophysiology
2023Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy CANCER RESEARCH AND TREATMENT
2023Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data TRANSLATIONAL LUNG CANCER RESEARCH
2023Real-World Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the Era of Current-Generation Devices JOURNAL OF CLINICAL MEDICINE
2023Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors TRANSLATIONAL LUNG CANCER RESEARCH
2023Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia JOURNAL OF CLINICAL HYPERTENSION
2023Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma JOURNAL OF CLINICAL ONCOLOGY
2023Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus PLOS ONE
2023Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2023Preface CLINICAL AND MOLECULAR HEPATOLOGY
2023Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach SCIENTIFIC REPORTS
2023Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study PLOS ONE
2023Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer FUTURE ONCOLOGY

Recent Submissions

Browse

Links